Medical Co. Execs Say Claims They Diluted Stock Are Flimsy
The majority shareholders of Medite Cancer Diagnostics Inc. only served one of the company's five board members named in their derivative suit alleging the directors diluted company shares to keep their jobs, indicating their claims...To view the full article, register now.
Already a subscriber? Click here to view full article